| Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141 (NCT05652595) | Geropharm | 2022-06-03 |
| Clinical Decision Support Tool for Vancomycin Dosing in Children (NCT04911270) | University of Maryland, Baltimore | 2022-05-09 |
| Effect of Oral Water in Healthy Volunteers on Cardiac Output, Regional Flow and Microcirculation in Healthy Volunteers (NCT05153837) | Centre Hospitalier Universitaire, Amiens | 2021-11-30 |
| Study of DTRI-031 in Healthy Volunteers (NCT05005520) | Basking Biosciences, Inc. | 2021-10-20 |
| Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products (NCT04183491) | Food and Drug Administration (FDA) | 2020-02-28 |
| Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists (NCT04183192) | Food and Drug Administration (FDA) | 2020-02-17 |
| Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile Neutropenia (NCT04250038) | Universitaire Ziekenhuizen KU Leuven | 2019-08-01 |
| Modeling and Application of Triple Drug Response Surface Models (NCT03813875) | Taipei Veterans General Hospital, Taiwan | 2019-06-12 |
| The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin (NCT03895229) | Ain Shams University | 2018-10-01 |
| A Phase 1 Study of Tegoprazan on Healthy Male Volunteers (NCT03530228) | HK inno.N Corporation | 2018-05-01 |
| A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers (NCT03378284) | HK inno.N Corporation | 2017-12-10 |
| Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric (NCT03337581) | Chinese Medical Association | 2017-10-20 |
| Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor (NCT03161002) | Cui Yimin | 2017-05-31 |
| CiPA Phase 1 ECG Biomarker Validation Study (NCT03070470) | Food and Drug Administration (FDA) | 2017-03-14 |
| A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567. (NCT02512575) | AstraZeneca | 2015-11-18 |
| A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects (NCT02532998) | AstraZeneca | 2015-09-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants (NCT02209506) | Takeda | 2014-07-01 |
| Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current Block (NCT02308748) | Food and Drug Administration (FDA) | 2014-05-01 |
| Clopidogrel And Ticagrelor in Healthy Subjects (NCT02086903) | Dong-A University | 2014-02-01 |
| A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given Together (NCT02085863) | Teva Branded Pharmaceutical Products R&D, Inc. | 2014-02-01 |
| Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products (NCT02010632) | Khon Kaen University | 2013-08-01 |
| Eplerenone and Extracellular Adenosine Formation (NCT01837108) | Radboud University Medical Center | 2013-04-01 |
| Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer. (NCT01692262) | AstraZeneca | 2012-11-01 |
| A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects (NCT01815684) | Astellas Pharma Europe B.V. | 2012-08-01 |
| A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability (NCT01958047) | Astellas Pharma Europe B.V. | 2012-07-01 |
| Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206 (NCT01954589) | Idorsia Pharmaceuticals Ltd. | 2011-11-01 |
| Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules (NCT01226316) | AstraZeneca | 2010-12-01 |
| A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin (NCT01214122) | AstraZeneca | 2010-11-01 |
| Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study (NCT01158755) | Universitas Padjadjaran | 2010-10-01 |
| Effect of Itraconazole and Ticlopidine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol (NCT01214941) | Turku University Hospital | 2010-09-01 |
| Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2 (NCT00810303) | University Medicine Greifswald | 2009-03-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K (NCT01364974) | Astellas Pharma Inc | 2009-01-01 |
| Pharmacodynamic Characterization of Dienogest (NCT00754871) | Bayer | 2008-09-01 |
| Propofol in Obese Children (NCT01242241) | Baylor College of Medicine | 2008-04-01 |
| A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body (NCT01655056) | Astellas Pharma Europe B.V. | 2006-06-01 |